Procaps Group SA (PROC), a global pharmaceutical company based in Colombia, is an industry leader known for its high-quality production of softgel capsules and advanced drug delivery systems. The company is dedicated to the development, production, and marketing of over-the-counter (OTC) drugs, prescription medications, and nutritional supplements.
Founded in 1977, Procaps Group SA has grown to become a highly innovative company. Its pioneering spirit has led to the development of several patented drug delivery technologies, making it a highly sought-after partner in the pharmaceutical and wellness industries. Procaps helps pharmaceutical organizations worldwide increase the effectiveness, safety, and stability of their products by encapsulating them in easily digested softgel capsules, thereby improving the lives of millions around the world.
The company's culturally diverse team of professionals leverages its deep industrial expertise to deliver differentiated pharmaceutical solutions that promote health and wellness across the globe. With a keen focus on research and development, Procaps consistently pioneers new methodologies to improve delivery systems, offering a broad portfolio of over 500 products sold across 50 different countries.
Procaps Group SA is reputed for its exceptional manufacturing capabilities and operates one of the largest integrated softgel facilities in Latin America and the Caribbean. It's also known for its commitment to sustainable practices and environmental responsibility. Sustainability is deeply ingrained in Procaps’ corporate culture. The company continually strives to reduce its environmental footprint by employing green technologies and promoting the responsible use of natural resources.
In addition to its core capabilities, the company offers an array of integrated packaging solutions, ranging from primary packaging (blisters and bottles) to secondary and tertiary packaging (cartons and bundles), ensuring clients get a complete end-to-end service.
Procaps has proved its exceptional proficiency with accreditations from various international regulatory authorities, including the U.S. Food & Drug Administration (FDA), ANVISA in Brazil, Health Canada, and INVIMA in Colombia. The company’s standards of corporate governance are illustrative of its commitment to ethical business practices.
Procaps Group SA consistently aims to improve its technological capabilities to facilitate the delivery of high-quality pharmaceutical products. With a constant eye on innovation and a commitment to exceptional standards of governance, Procaps is truly a trusted partner in the global pharmaceutical industry.